Manufacturer record
Hariom Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Hariom Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between July 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: HPT25002, Amoxycillin & Potassium Clavulanate Tablets I.P (exp Nov 2026). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay and Dissolution" of Amoxycillin and Clavulanic. Listed in the September 2026 alert.
Records by type
2 records linked to Hariom Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin & Potassium Clavulanate Tablets I.P | Batch HPT25002Mfg Jun 2025 · Exp Nov 2026 | The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay and Dissolution" of Amoxycillin and Clavulanic Acid.Assay | RDTL, GuwahatiCDSCO lab | Sep 2026 |
| Amoxycillin & Potassium Clavulanate Tablets I.P. | Batch HPT25002Mfg Jun 2025 · Exp Nov 2026 | The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay and Dissolution of Amoxycillin and Clavulanic Acid.Assay | RDTL, GuwahatiCDSCO lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.